Literature DB >> 15485629

T cell division and death are segregated by mutation of TCRbeta chain constant domains.

Emma Teixeiro1, Mark A Daniels, Barbara Hausmann, Adam G Schrum, Dieter Naeher, Immanuel Luescher, Margot Thome, Rafael Bragado, Ed Palmer.   

Abstract

We have studied the role of the T cell receptor (TCR) beta chain transmembrane and cytoplasmic domains (betaTM/Cyto) in T cell signaling. Upon antigen stimulation, T lymphocytes expressing a TCR with mutant and betaTM and Cyto domains accumulate in large numbers and are specifically defective in undergoing activation-induced cell death (AICD). The mutant TCR poorly recruits the protein adaptor Carma-1 and is subsequently impaired in activating NF-kappaB. This signaling defect leads to a reduced expression of Fas ligand (FasL) and to a reduction in AICD. These beta chain domains are involved in discriminating cell division and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15485629     DOI: 10.1016/j.immuni.2004.08.014

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  14 in total

1.  IP-FCM: immunoprecipitation detected by flow cytometry.

Authors:  Tessa R Davis; Adam G Schrum
Journal:  J Vis Exp       Date:  2010-12-02       Impact factor: 1.355

2.  High-sensitivity detection and quantitative analysis of native protein-protein interactions and multiprotein complexes by flow cytometry.

Authors:  Adam G Schrum; Diana Gil; Elaine P Dopfer; David L Wiest; Laurence A Turka; Wolfgang W A Schamel; Ed Palmer
Journal:  Sci STKE       Date:  2007-06-05

3.  The SCHOOL of nature: I. Transmembrane signaling.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-01

4.  The early proximal αβ TCR signalosome specifies thymic selection outcome through a quantitative protein interaction network.

Authors:  Steven C Neier; Alejandro Ferrer; Katelynn M Wilton; Stephen E P Smith; April M H Kelcher; Kevin D Pavelko; Jenna M Canfield; Tessa R Davis; Robert J Stiles; Zhenjun Chen; James McCluskey; Scott R Burrows; Jamie Rossjohn; Deanne M Hebrink; Eva M Carmona; Andrew H Limper; Dietmar J Kappes; Peter J Wettstein; Aaron J Johnson; Larry R Pease; Mark A Daniels; Claudia Neuhauser; Diana Gil; Adam G Schrum
Journal:  Sci Immunol       Date:  2019-02-15

5.  Multiplex IP-FCM (immunoprecipitation-flow cytometry): Principles and guidelines for assessing physiologic protein-protein interactions in multiprotein complexes.

Authors:  Anya T Bida; Diana Gil; Adam G Schrum
Journal:  Methods       Date:  2011-09-16       Impact factor: 3.608

6.  Physical and functional bivalency observed among TCR/CD3 complexes isolated from primary T cells.

Authors:  Adam G Schrum; Diana Gil; Laurence A Turka; Ed Palmer
Journal:  J Immunol       Date:  2011-06-10       Impact factor: 5.422

7.  Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability.

Authors:  Cyrille J Cohen; Yangbing Zhao; Zhili Zheng; Steven A Rosenberg; Richard A Morgan
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

8.  IL-12 Signals through the TCR To Support CD8 Innate Immune Responses.

Authors:  Nicholas P Goplen; Vikas Saxena; Karin M Knudson; Adam G Schrum; Diana Gil; Mark A Daniels; Rose Zamoyska; Emma Teixeiro
Journal:  J Immunol       Date:  2016-08-12       Impact factor: 5.422

9.  Public and private human T-cell clones respond differentially to HCMV antigen when boosted by CD3 copotentiation.

Authors:  Laura R E Becher; Wendy K Nevala; Shari Lee Sutor; Megan Abergel; Michele M Hoffmann; Christopher A Parks; Larry R Pease; Adam G Schrum; Svetomir N Markovic; Diana Gil
Journal:  Blood Adv       Date:  2020-11-10

10.  Antigen-specific human T-cell responses and T cell-dependent production of human antibodies in a humanized mouse model.

Authors:  Noriko Tonomura; Katsuyoshi Habiro; Akira Shimizu; Megan Sykes; Yong-Guang Yang
Journal:  Blood       Date:  2008-02-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.